XML 82 R36.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies -Disaggregated By Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Disaggregation of Revenue [Line Items]    
Total revenue $ 203,471 $ 168,491
Oncology    
Disaggregation of Revenue [Line Items]    
Total revenue 150,559 125,748
Biopharma and data    
Disaggregation of Revenue [Line Items]    
Total revenue 45,376 37,587
Screening    
Disaggregation of Revenue [Line Items]    
Total revenue 5,677 0
Licensing and other    
Disaggregation of Revenue [Line Items]    
Total revenue $ 1,859 $ 5,156